Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.

被引：0
|
作者：
Mies, Sergio [1 ]
Beduschi, Thiago [1 ]
Silva, Vinicius M. R. [1 ]
Mies, Ana Olga N. G. F. [1 ]
Della Guardia, Bianca [1 ]
Baia, Carlos E. S. [1 ]
de Almeida, Marcio D. [1 ]
机构：
[1] Albert Einstein Hosp, Liver Unit, Sao Paulo, Brazil
来源：
LIVER TRANSPLANTATION | 2007年 / 13卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
441
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [21] Decreased Expression of Pro-Carcinogenic Genes Following Tacrolimus to Sirolimus Conversion in Liver Transplant Recipients.
    Bhat, M.
    Pasini, E.
    Baciu, C.
    Kurian, S.
    Levitsky, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 753 - 753
  • [22] Conversion to and from sirolimus in renal and hepatic transplant recipients treated with calcineurin inhibitors: Effect on renal function.
    Moneim, HA
    Flechner, SM
    George, P
    Derweesh, IH
    Modlin, C
    Krishnamurthi, V
    Goldfarb, D
    Novick, AC
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 376 - 377
  • [23] Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
    Yu, Ji Hyun
    Kim, Kyoung Woon
    Kim, Bo-Mi
    Chung, Byung Ha
    Cho, Mi-La
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2016, 31 (03): : 552 - 559
  • [24] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
  • [25] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    [J]. TRANSPLANTATION, 2014, 98 : 714 - 715
  • [26] EFFECT OF SIROLIMUS ON IMMUNE CELL FUNCTION ASSAY IN LIVER TRANSPLANT RECIPIENTS.
    Tu, C.
    Gish, R. G.
    Kuo, A.
    Collins, C.
    Tsunoda, S. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S66 - S66
  • [27] Improvement in renal function following introduction of sirolimus in liver transplant recipients.
    Laura, ML
    Gores, GJ
    Kremers, WK
    Wiesner, RH
    Brandhagen, DJ
    Menon, KVN
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 364 - 364
  • [28] The Efficacy and Limitations of Sirolimus Conversion in Liver Transplant Patients Who Develop Renal Dysfunction on Calcineurin Inhibitors
    Patrick Lam
    Atsushi Yoshida
    Kimberly Brown
    Marwan Abouljoud
    Iman Bajjoka
    Fadi Dagher
    Dilip K. Moonka
    [J]. Digestive Diseases and Sciences, 2004, 49 : 1029 - 1035
  • [29] The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors
    Lam, P
    Yoshida, A
    Brown, K
    Abouljoud, M
    Bajjoka, I
    Dagher, F
    Moonka, DK
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1029 - 1035
  • [30] Calcineurin Inhibitors, Macrolides, and the Risk of Adverse Drug Events in Kidney Transplant Recipients.
    Jeong, R.
    Quinn, R.
    Ravani, P.
    Lentine, K.
    Lloyd, A.
    Hemmelgarn, B.
    Wen, K.
    Braam, B.
    Gourishankar, S.
    Wong, A.
    Lam, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 807 - 807
12345